ibrutinib,rituximab
abbvie,janssen
[' ibru', 'lymphoma']
results from triangle presented at #ash22: ffs was superior with asct plus ibrutinib vs asct alone ffs was not superior with asct alone vs ibrutinib alone still unclear if asct improves upon ibrutinib mx numeric os benefit with ibrutinib 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.